Spring Issue of GIST Cancer Journal has Arrived
The Life Raft Group is pleased to announce the release of the ninth issue of The GIST Cancer Journal, the official journal of the Life Raft Group. The journal is intended to serve as [...]
Leading GIST Experts Weigh in at ESMO
David Josephy On behalf of The Life Raft Group USA and Life Raft Group Canada, I attended the Sarcoma & GIST 2016 meeting organized by the European Society for Medical Oncology (ESMO) [...]
Proton Pump Inhibitors Linked to Kidney Disease
A recent study published in the JAMA Internal Medicine reports a link between the use of proton pump inhibitors (PPIs) and an increased risk of kidney disease. More research is warranted to show PPIs [...]
GIST Collaborative Tissue Bank: A researcher’s perspective
The Life Raft Group GIST Collaborative Tissue Bank consists of a collection of tumor specimens from a large number of patients, stored at Stanford University. The advantages of having a tissue bank for a [...]
GIST Cancer Journal Winter 2015 Issue
The Life Raft Group is pleased to announce the release of the eighth issue of The GIST Cancer Journal, the official journal of the Life Raft Group and the first academic journal devoted solely [...]
Liquid Biopsy Holds Promise for Precision Medicine
In a recent release from the Translational Genomics Research Institute (TGen), it was reported that researchers have discovered that by analyzing circulating tumor DNA (ctDNA) through liquid biopsy that a patient's cancer can be tracked [...]
Connective Tissue Oncology Society (CTOS) Annual Meeting Update
Today’s researchers estimate that there are over 200 classified cancers today and that one out of three people will be affected by it at some stage in their life. With the extreme prevalence of cancer [...]
Sebastian Bauer Awarded the 2015 GIST Group Switzerland Science Prize
LRG research team member, Dr. Sebastian Bauer recently received the 6th Annual Science Prize awarded by the GIST Group Switzerland on November 26, 2015 at the semi-annual meeting of the Swiss Group for Clinical [...]
Adjuvant Imatinib Study Updates Results
A recent study further documented the advantage of three years of adjuvant imatinib versus one year in high-risk GIST patients. The study, which is to be published in the Journal of Clinical Oncology, was authored by [...]
Gut Microbes and Their Role in Immunotherapy
Immunotherapy is a promising area in cancer research and in emerging treatments. Several new studies highlight the role that gut microbes may play in the efficacy of immunotherapy treatments.In a recent article in the Atlantic, [...]